» Articles » PMID: 38843497

Role and Mechanism of KIAA1429 in Regulating Cellular Ferroptosis and Radioresistance in Colorectal Cancer

Overview
Journal Biomol Biomed
Date 2024 Jun 6
PMID 38843497
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is one of the most common non-cutaneous malignancies, causing significant mortality and a substantial burden. This study aims to explore the role of KIAA1429 (also known as vir-like m6A methyltransferase associated [VIRMA]) protein in the radioresistance of CRC. CRC cells and a radioresistant cell line were cultured, and KIAA1429 expression was detected. After the down-regulation of KIAA1429, its effect on the radioresistance and ferroptosis of cancer cells was analyzed. The role of ferroptosis in radioresistance was verified. The binding relationship among long non-coding RNA endogenous Bornavirus-like nucleoprotein 3, pseudogene (lncRNA EBLN3P), microRNA (miR)-153-3p, and KIAA1429 was analyzed. KIAA1429 and lncRNA EBLN3P were highly expressed in CRC, while miR-153-3p was poorly expressed. KIAA1429 and lncRNA EBLN3P were further increased/decreased in the radioresistant cells. KIAA1429 knockdown decreased the survival rate of the radioresistant cell line after X-ray irradiation and increased gamma H2A histone family member X (γ-H2AX), ferroptosis, and oxidative stress. A ferroptosis inhibitor alleviated the inhibitory effect of KIAA1429 knockdown on radioresistance. KIAA1429-mediated m6A modification up-regulated lncRNA EBLN3P, and lncRNA EBLN3P increased KIAA1429 by competitively binding to miR-153-3p. miR-153-3p silencing or lncRNA EBLN3P overexpression attenuated the promotion of ferroptosis and the inhibition of radioresistance induced by KIAA1429 knockdown. Overall, KIAA1429-mediated m6A modification up-regulated lncRNA EBLN3P expression, and lncRNA EBLN3P increased KIAA1429 expression by competitively binding to miR-153-3p, thus reducing ferroptosis and increasing the radioresistance of CRC.

References
1.
Tang H, Huang H, Guo Z, Huang H, Niu Z, Ji Y . Heavy Ion-Responsive lncRNA EBLN3P Functions in the Radiosensitization of Non-Small Cell Lung Cancer Cells Mediated by TNPO1. Cancers (Basel). 2023; 15(2). PMC: 9856274. DOI: 10.3390/cancers15020511. View

2.
Huang X, Wu J, Wang Y, Xian Z, Li J, Qiu N . FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643/miR-153/SLC7A11 axis. Exp Cell Res. 2023; 431(1):113737. DOI: 10.1016/j.yexcr.2023.113737. View

3.
Lu Z, Xiao B, Chen W, Tang T, Zhuo Q, Chen X . The potential of ferroptosis combined with radiotherapy in cancer treatment. Front Oncol. 2023; 13:1085581. PMC: 10064444. DOI: 10.3389/fonc.2023.1085581. View

4.
Bridges M, Daulagala A, Kourtidis A . LNCcation: lncRNA localization and function. J Cell Biol. 2021; 220(2). PMC: 7816648. DOI: 10.1083/jcb.202009045. View

5.
Chen X, Zhang J, Zhu J . The role of mA RNA methylation in human cancer. Mol Cancer. 2019; 18(1):103. PMC: 6540575. DOI: 10.1186/s12943-019-1033-z. View